Phase II clinical trial of lastet capsule in combination chemotherapy of malignant tumors in China

1995 ◽  
Vol 7 (3) ◽  
pp. 181-186
Author(s):  
Tianze Zhang ◽  
Jiliang Yin ◽  
Youjian He ◽  
Deyuan Wang ◽  
Yi Wang
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Combination Chemotherapy ◽  
Malignant Tumors ◽  
Phase Ii Clinical Trial

Phase II Clinical Trial of Combination Chemotherapy With Dexamethasone for Lymphoma in Dogs

2007 ◽  
Vol 43 (1) ◽  
pp. 27-32 ◽  
Author(s):  
Chelsea B. Greenberg ◽  
Pedro A. Boria ◽  
Antonella Borgatti-Jeffreys ◽  
Rose E. Raskin ◽  
Michael D. Lucroy
Keyword(s):  
Clinical Trial ◽  
Complete Remission ◽  
Induction Chemotherapy ◽  
Phase Ii ◽  
Combination Chemotherapy ◽  
Phase Ii Clinical Trial ◽  
Two Stage ◽  
Stage Design ◽  
Free Interval ◽  
Chemotherapy Protocol

Dogs with histologically confirmed lymphoma were treated with a 14-week induction chemotherapy protocol that included dexamethasone. A phase II clinical trial was done using a standard two-stage design. Complete remission occurred in 21 (88%) dogs, with a median initial progression-free interval of 186 days. Toxicity was mild and self-limiting in the majority of dogs.

REGOMA: A Randomized, Multicenter, Controlled Open-Label Phase II Clinical Trial of Regorafenib Compared to Lomustine in Relapsed Glioblastoma Patients

2018 ◽  
Author(s):  
Giuseppe Lombardi ◽  
Gian Luca De Salvo ◽  
Alba Ariela Brandes ◽  
Marica Eoli ◽  
Roberta Rudà ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document